
About Revacure Lifesciences LLP
Data last updated:
Revacure Lifesciences LLP is a limited liability partnership (LLP) based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 August 2015 and has been in existence for over 11 years.
The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAE-5788. Its GSTIN is 23AASFR8544G2ZR (Madhya Pradesh). The LLP holds 3 GST registrations, of which 1 is active.
The LLP has a total obligation of contribution of ₹75,000. It is led by designated partners including Neeti Bhardwaj and Rajeev Saxena.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at A – 63 Sarita Vihar, Delhi, India – 110076.
As per the financials filed for FY 2020, the LLP reported a revenue of ₹10.81 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.68 Cr (net margin -15.5%) and EBITDA of ₹9.18 Cr (EBITDA margin 84.9%).
The LLP has about 11 employees on its provident fund (EPFO) records.
As per MCA filings, the LLP has open charges of ₹9.85 Cr on record. Court records list 7 cases involving the LLP, including 3 filed by the LLP and 4 filed against it; 1 case is pending.
For more details, the LLP can be reached via its website revacurelifesciences.com.
Company details
Contact details
Revacure Lifesciences LLP's registered office is in Delhi, Delhi. Its website is revacurelifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA – 63 Sarita Vihar, Delhi, India – 110076
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Revacure Lifesciences LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Revacure Lifesciences LLP
FY 2025 filings availableRevacure Lifesciences LLP reported revenue of ₹10.81 Cr (up 362% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue rose 362% in the latest year. EBITDA rose 196% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | ₹10.81 Cr | ||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | -₹1.68 Cr | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | -15.5% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Revacure Lifesciences LLP, buy the company report.
Designated partners of Revacure Lifesciences LLP
Revacure Lifesciences has 3 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neeti Bhardwaj Also directs: CGMP Pharma 'N' Plans Private Limited | Designated Partner | 17 Aug 2015 | 11 Years 2 Months | Current |
| Rajeev Saxena | Designated Partner | 17 Aug 2015 | 11 Years 2 Months | Current |
| Ravi Saxena Also directs: CGMP Pharma 'N' Plans Private Limited | Designated Partner | 17 Aug 2015 | 11 Years 2 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Feb 2016 | 100016041 | Allahabad Bank | ₹9.85 Cr | Open |
To see the full charge records of Revacure Lifesciences LLP, buy the company report.
Total charge records: 1 View all charges
Legal cases
Revacure Lifesciences LLP has 7 court cases on record: 3 filed by Revacure Lifesciences, 4 filed against it. 1 case is pending and 6 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 3 | 0 |
| High courts | 3 | 1 | 1 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (FAO (COMM)) | Filed by the company against M/S Bhardwaj India Pvt. Ltd | Pending |
| District court, South East, Delhi | Court case (OMP (COMM.)) | Filed against the company by M/S Bhardwaj India Pvt Ltd | Disposed |
| High Court of Delhi | Arbitration matter | Filed against the company by M/S Bhardwaj India Pvt Ltd | Disposed |
| District court, South East, Delhi | Court case (Cr CASES) | Filed against the company by State | Disposed |
| District court, South East, Delhi | Interim or miscellaneous application | Filed against the company by State | Disposed |
To see the full case history of Revacure Lifesciences LLP, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Revacure Lifesciences LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Revacure Lifesciences LLP has a workforce of 12 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
GST
Revacure Lifesciences has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AASFR8544G2ZR | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Revacure Lifesciences LLP, buy the company report.
Recent activity
Revacure Lifesciences LLP has 3 designated partner changes on record since 2015: 3 appointments. The latest: Neeti Bhardwaj was appointed as Designated Partner on 17 Aug 2015.
Frequently asked questions
Revacure Lifesciences is an active limited liability partnership based in Delhi, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 17 August 2015 (11+ years old) and is registered under LLPIN AAE-5788.
Revacure Lifesciences has 3 current designated partners:
- Neeti Bhardwaj - Designated Partner
- Rajeev Saxena - Designated Partner
- Ravi Saxena - Designated Partner
The latest financial statements of Revacure Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Revacure Lifesciences is 23AASFR8544G2ZR, registered in Madhya Pradesh. The LLP has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The LLPIN (Limited Liability Partnership Identification Number) of Revacure Lifesciences is AAE-5788. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Revacure Lifesciences has 7 court cases on record: 3 filed by the LLP and 4 filed against it. 1 is pending. Most are in the district courts.
Revacure Lifesciences was incorporated on 17 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Neeti Bhardwaj was appointed as Designated Partner on 17 Aug 2015. Rajeev Saxena was appointed as Designated Partner on 17 Aug 2015. Ravi Saxena was appointed as Designated Partner on 17 Aug 2015.
Revacure Lifesciences can be reached through the website revacurelifesciences.com. Its registered office is in Delhi, India.
The registered office of Revacure Lifesciences is at A – 63 Sarita Vihar, Delhi, India – 110076.

